NguyenP.L., D'AmicoAV, LeeA.K., SuhW.W.: Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer, 110: 1417–1428, 2007.
2.
AhmedH.U., IshaqA., ZacharakisE., ShawG., IllingR., AllenC., KirkhamA., EmbertonM.: Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int. 2009, 103: 321–323, 2009.
3.
FowlerJ., ChappellR., RitterM.: Is alpha/beta for prostate tumors really low?Int J Radiat Oncol Biol Phys, 50: 1021–1031, 2001.
4.
DasuA.: Is the α/β value for prostate tumours low enough to be safely used in clinical trials?Clin Oncol (R Coll Radiol), 19: 289–301, 2007.
5.
FowlerJ.F., NahumA.E., OrtonC.G.: Point/Counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. Med Phys, 33: 3081–3084, 2006.
6.
FullerD.B., NaitohJ., LeeC., HardyS., JinH.: Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys, 70(5): 1588–1597, 2008.
7.
VavassoriA., Jereczek-FossaB.A., BeltramoG., De CiccoL., FariselliL., BianchiL.C., PossanziniM., BergantinA., DeCobelliO., OrecchiaR.: Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: retrospective feasibility study on six cases. Tumori, 96: 71–75, 2010.
